Pituitary antibodies and lymphocytic hypophysitis

Area of Science:

• Endocrinology
• Immunology
• Neurology

Background:

• Lymphocytic hypophysitis (LYH) is an autoimmune pituitary disorder presenting with symptoms like headache and visual field changes.
• LYH is associated with other autoimmune conditions, reinforcing its classification as an autoimmune disease.
• While trans-sphenoidal biopsy is the gold standard, MRI findings can suggest LYH.

Purpose of the Study:

• To investigate the diagnostic and pathogenetic roles of anti-pituitary antibodies (APAs) in Lymphocytic hypophysitis (LYH).
• To clarify the clinical relevance of APAs given conflicting results from various detection methods.

Main Methods:

• Review of clinical, histopathological, and morphological findings in LYH.
• Analysis of studies detecting APAs using different methodologies, including immunofluorescence.
• Correlation of APA detection with specific pituitary dysfunctions, particularly growth hormone deficiency.

Main Results:

• Conflicting results from different APA detection methods have limited their clinical utility.
• Recent studies detected APAs using immunofluorescence in patients with idiopathic hypopituitarism and autoimmune endocrine diseases.
• High titres of APAs appear to be a significant marker for pituitary involvement, especially affecting growth hormone-producing cells.

Conclusions:

• The diagnostic value of APAs in LYH remains under discussion due to methodological inconsistencies.
• High-titre APAs, particularly detected by immunofluorescence, may serve as a valuable marker for pituitary involvement in autoimmune conditions.
• Further standardization of APA detection methods is needed to enhance their clinical relevance in diagnosing and understanding LYH.